Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation.

作者: Ronald L. Sham , Pradyumna D. Phatak , Elizabeta Nemeth , Tomas Ganz

DOI: 10.1182/BLOOD-2009-04-216226

关键词:

摘要: To the editor: The different genetic forms of hereditary hemochromatosis share as their pathogenic mechanisms deficiency or dysregulation hormone hepcidin defects involving receptor, ferroportin.1 Ferroportin is sole known cellular iron exporter in humans and present on enterocytes, macrophages, hepatocytes.2 Normally, cell-surface concentration ferroportin regulated by its interaction with hepcidin. Hepcidin binding triggers internalization degradation ferroportin-hepcidin complex, causing a decrease release into plasma.3 Mutations (SLC40A1) gene cause overload syndromes autosomal dominant transmission.4 mutations at least 2 distinct phenotypes, depending functional alteration protein. One subtype mutations, predominantly residues located putative cytoplasmic side transmembrane segments (eg, V162del, D157G, G80S, G490D), results loss export function.5 This leads to increased macrophage elevated serum ferritin, but normal transferrin saturation. phenotype, referred “ferroportin disease,” does not appear have significant morbidity. A ferroportin-related similar classical hemochromatosis, associated gain-of-function (eg N144D/T/H, Y64N, C326S/Y).6,7 In vitro evidence (companion manuscript, Fernandes et al8) indicates that these ferroportin's resistance effects N144D/T Y64N prevent hepcidin-ferroportin complex while C326S mutation completely ablates ferroportin. We previously reported most severe phenotype early age onset.6 In this study, we measured indices members family carrying heterozygous mutations.6 was competitive ELISA8 (Intrinsic LifeSciences, La Jolla, CA). The subjects had already been treated phlebotomy normalized stores, assessed saturation remained high (Table 1). patients (IIIC) has become iron-deficient due combined menstrual blood loss. Except for patient IIIC, all affected urinary concentrations upper limit range above These relatively levels are probably consequence patients' Only IIIC lower hepcidin, likely reflecting appropriate response deficiency. The despite depleted stores contrast low undetectable observed HFE, receptor 2, hemojuvelin hemochromatosis.9–11 Thus, our study provides first direct can be caused absence mutant excessive activity duodenal enterocytes unrestrained dietary absorption, which would account early-onset systemic seen juvenile hemochromatosis. Our findings support concept parenchymal iron-loading either effect

参考文章(11)
Elizabeta Nemeth, Marie S Tuttle, Julie Powelson, Michael B Vaughn, Adriana Donovan, Diane McVey Ward, Tomas Ganz, Jerry Kaplan, Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization Science. ,vol. 306, pp. 2090- 2093 ,(2004) , 10.1126/SCIENCE.1104742
Augustine Fernandes, Gloria C. Preza, Yen Phung, Ivana De Domenico, Jerry Kaplan, Tomas Ganz, Elizabeta Nemeth, The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood. ,vol. 114, pp. 437- 443 ,(2009) , 10.1182/BLOOD-2008-03-146134
Elizabeta Nemeth, Antonella Roetto, Giovanni Garozzo, Tomas Ganz, Clara Camaschella, Hepcidin is decreased in TFR2 hemochromatosis. Blood. ,vol. 105, pp. 1803- 1806 ,(2005) , 10.1182/BLOOD-2004-08-3042
Adriana Donovan, Christine A. Lima, Jack L. Pinkus, Geraldine S. Pinkus, Leonard I. Zon, Sylvie Robine, Nancy C. Andrews, The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis Cell Metabolism. ,vol. 1, pp. 191- 200 ,(2005) , 10.1016/J.CMET.2005.01.003
A Pietrangelo, The ferroportin disease. Blood Cells Molecules and Diseases. ,vol. 32, pp. 131- 138 ,(2004) , 10.1016/J.BCMD.2003.08.003
Ronald L. Sham, Pradyumna D. Phatak, Carol West, Pauline Lee, Caroline Andrews, Ernest Beutler, Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Molecules and Diseases. ,vol. 34, pp. 157- 161 ,(2005) , 10.1016/J.BCMD.2004.12.002
Daniel F Wallace, V Nathan Subramaniam, Non-HFE haemochromatosis. World Journal of Gastroenterology. ,vol. 13, pp. 4690- 4698 ,(2007) , 10.3748/WJG.V13.I35.4690
George Papanikolaou, Mark E Samuels, Erwin H Ludwig, Marcia L E MacDonald, Patrick L Franchini, Marie-Pierre Dubé, Lisa Andres, Julie MacFarlane, Nikos Sakellaropoulos, Marianna Politou, Elizabeta Nemeth, Jay Thompson, Jenni K Risler, Catherine Zaborowska, Ryan Babakaiff, Christopher C Radomski, Terry D Pape, Owen Davidas, John Christakis, Pierre Brissot, Gillian Lockitch, Tomas Ganz, Michael R Hayden, Y Paul Goldberg, Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics. ,vol. 36, pp. 77- 82 ,(2004) , 10.1038/NG1274
Tomas Ganz, Molecular Control of Iron Transport Journal of The American Society of Nephrology. ,vol. 18, pp. 394- 400 ,(2007) , 10.1681/ASN.2006070802
Hal Drakesmith, Lisa M. Schimanski, Emma Ormerod, Alison T. Merryweather-Clarke, Vip Viprakasit, Jon P. Edwards, Emma Sweetland, Judy M. Bastin, Diana Cowley, Yingyong Chinthammitr, Kathryn J. H. Robson, Alain R. M. Townsend, Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. ,vol. 106, pp. 1092- 1097 ,(2005) , 10.1182/BLOOD-2005-02-0561